Company profile
Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ: LMRI · Healthcare · Medical - Devices
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 42
v0.1 · 5/100 weight · pillars only
↑ Piotroski F, market scale · ↓ listing tenure, filing timeliness
Methodology →Revenue TTM
$1.0B
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
—
Employees
—
as of 2026-08-18
Market cap
$1.0B
as of 2026-08-18
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Lumexa Imaging Holdings, Inc. Common Stock’s financial profile?
Lumexa Imaging Holdings, Inc. Common Stock has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Olema Pharmaceuticals, Inc.——Replimune Group, Inc.——Alto Neuroscience, Inc.——Sana Biotechnology, Inc.——Annexon, Inc.——Faeth Therapeutics, Inc.——Neighbors
Wake →Key facts
CEOCaitlin Zulla
SectorHealthcare
IndustryMedical - Devices
HeadquartersRaleigh, NC
ExchangeNASDAQ: LMRI
Employees—
IPO date2025-12-11
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.